ProjectAnalysis of Tumor-associated antigens (TAAs) in childhood melanoma4

Basic data

Title:
Analysis of Tumor-associated antigens (TAAs) in childhood melanoma4
Duration:
6/14/2021 to 6/14/2022
Abstract / short description:
RNA based cancer vaccines can induce an immune response directed against tumor antigens in melanoma patients (1). The investigational drug FixVac (BNT111) targets four non-mutated, tumor-associated antigens that are expressed in adult melanoma. However, there is no data available regarding expression of these antigens in childhood melanoma. The goal of this study is to examine the expression of TAAs in childhood melanoma in the context of developing FixVac (BNT111) for the treatment of childhood melanomas.

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen

Contact persons

Faculty of Medicine
University of Tübingen
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Mainz, Rheinland-Pfalz, Germany
Help

will be deleted permanently. This cannot be undone.